Lucius Pharmaceuticals

【TiVozanib】 in Advanced Renal Cell Carcinoma Treatment

Date:2025-1-21 Views:948

TiVozanib, marketed as LuciTivo by Lucius Pharmaceuticals, represents a significant advancement in the treatment of advanced renal cell carcinoma (RCC). Available in 0.89 mg and 1.34 mg capsule forms, this targeted therapy provides a focused and effective approach to managing cancer, reducing the reliance on traditional chemotherapy.

【TiVozanib】 in Advanced Renal Cell Carcinoma Treatment
TiVozanib 0.89 mg capsule forms
【TiVozanib】 in Advanced Renal Cell Carcinoma Treatment
TiVozanib 1.34 mg capsule forms

TiVozanib is a highly selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2, and 3. These receptors are vital for angiogenesis, the process by which tumors create new blood vessels to sustain growth. By blocking VEGF receptors, TiVozanib cuts off the tumor’s blood supply, inhibiting its growth and spread while sparing healthy cells.

【TiVozanib】 in Advanced Renal Cell Carcinoma Treatment
TiVozanib 0.89 mg Capsule License
【TiVozanib】 in Advanced Renal Cell Carcinoma Treatment
TiVozanib 1.34mg Capsule License
  • Targeted Therapy: Specifically focuses on cancerous growths, reducing side effects associated with non-targeted treatments.
  • Enhanced Progression-Free Survival: Clinical trials show significantly longer progression-free survival compared to placebo.
  • Improved Quality of Life: Patients report fewer adverse effects, allowing them to maintain a better standard of living during treatment.
【TiVozanib】 in Advanced Renal Cell Carcinoma Treatment
TiVozanib 0.89 mg Capsule Test Report
【TiVozanib】 in Advanced Renal Cell Carcinoma Treatment
TiVozanib 1.34mg Capsule Test Report

While TiVozanib is generally well-tolerated, some patients may experience the following:

  • Hypertension: Regular blood pressure monitoring is essential.
  • Fatigue: Common but manageable with adequate rest and light activities.
  • Gastrointestinal Issues: Nausea and diarrhea may occur but are often mild.
  • Hand-Foot Syndrome: Redness, swelling, and discomfort on palms and soles may require topical treatments.
  • Liver Function Abnormalities: Elevated liver enzymes necessitate regular blood tests.

Clinical studies underline the efficacy of TiVozanib in treating advanced RCC:

  • Progression-Free Survival: Patients treated with TiVozanib had an average progression-free survival of 16 months compared to 9 months for those on placebo.
  • Tumor Response: Many patients experienced tumor shrinkage, emphasizing its effectiveness as a first-line treatment.

To optimize treatment outcomes and maintain well-being, patients should:

  • Attend Regular Check-Ups: Frequent monitoring helps manage side effects and ensures treatment efficacy.
  • Follow a Balanced Diet: A nutrient-rich diet supports overall health and energy levels.
  • Engage in Light Exercise: Activities like walking or yoga can improve mood and reduce fatigue.
  • Stay Hydrated: Adequate hydration helps manage gastrointestinal side effects.
  • Seek Emotional Support: Joining support groups or consulting a counselor can help manage the psychological impact of cancer treatment.
【TiVozanib】 in Advanced Renal Cell Carcinoma Treatment
GMP Certificate of Lucius Pharmacuticals 卢修斯制药GMP证书
  • What is TiVozanib used for?
    It is indicated for advanced renal cell carcinoma.
  • How is LuciTivo taken?
    It is taken orally, usually once daily, with or without food.
  • What should I do if I miss a dose?
    Take it as soon as you remember, but skip it if it’s close to the next dose. Never double up.
  • Are there any contraindications?
    Patients allergic to TiVozanib or its components should not take it.
  • What monitoring is required?
    Blood pressure checks and liver function tests are crucial during treatment.
  • Is it safe during pregnancy?
    Women should avoid pregnancy while on TiVozanib due to potential risks.
  • What are the long-term effects?
    Long-term effects are under study; regular follow-ups are essential for ongoing evaluation.
  • Can TiVozanib treat other cancers?
    It is primarily for RCC, but research is exploring its use in other cancers.
  • How do I store TiVozanib?
    Store at room temperature, away from moisture and heat.
  • Where can I get TiVozanib?
    It is available through specialty pharmacies with a valid prescription.

Patients should review the medication guide accompanying LuciTivo for detailed instructions on usage, potential side effects, and when to contact a healthcare provider.

Resistance to TiVozanib may develop over time. Monitoring for changes in treatment response is critical. Precautions include:

  • Managing Hypertension: Keep blood pressure within a healthy range.
  • Liver Function Monitoring: Regular blood tests to detect liver-related side effects.
  • Adhere to the Schedule: Take TiVozanib at the same time each day.
  • Track Symptoms: Maintain a diary of symptoms and side effects to discuss during check-ups.
  • Communicate with Your Doctor: Report any new or worsening symptoms promptly.
  • True: TiVozanib targets VEGF receptors to inhibit tumor growth.
  • False: TiVozanib is a form of traditional chemotherapy.
  • True: Regular monitoring is necessary during treatment.
  • False: TiVozanib is safe to use without precautions regarding liver function.

Conclusion

TiVozanib (LuciTivo) represents a significant advancement in the management of advanced renal cell carcinoma. With its targeted mechanism, proven efficacy, and manageable side effects, LuciTivo offers hope for improved survival and quality of life. As Lucius Pharmaceuticals continues to innovate, the future of cancer care looks increasingly personalized and effective. Always consult your healthcare provider to determine if TiVozanib is the right treatment for you.

Original article, if reprinted, please indicate the link to this article: https://lucius-pharmaceuticals.com/%e3%80%90tivozanib%e3%80%91-in-advanced-renal-cell-carcinoma-treatment/

Related News